May 13, 2026 The use of AI in the life sciences sector and the impli... Artificial intelligence (AI) systems are increasingly becoming an effective and valuable tool in the life sciences sector. Their... Read more
May 1, 2026 Protecting, leveraging and enforcing IP around the worl... We always value the opportunity created by the INTA Annual Meeting to reconnect with our international lawyer contacts and our clients.... Read more
April 15, 2026 From space to science: how in‑orbit manufacturing is ... As part of its £2bn Life Sciences Sector Plan, the UK government has taken a global lead in announcing new measures to support the... Read more
April 8, 2026 Modernising UK clinical trials: what’s changing from ... The new UK clinical trials regime will accelerate the approval process for new medicines and enable patients to access treatments sooner... Read more
March 27, 2026 UK government position on text and data mining: what do... You probably already know that the UK government has “kicked the can down the road” on AI and copyright reform, concluding in its March... Read more
March 20, 2026 Digital twins in clinical trials: emerging IP considera... The emergence of AI-generated “digital twin” technology presents interesting new applications for life sciences businesses, including the... Read more
November 11, 2025 Not quite Reddy – lessons on strategy for generic lau... The recent High Court decision in Dr Reddy's Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH [2025] EWHC 2834 (Pat)... Read more
July 7, 2025 Healthcare financing and reimbursement in the UK – St... We were delighted to participate in the International Bar Association (IBA) Healthcare and Life Sciences Law Committee 2025 survey on... Read more
/Passle/611cdc4cfac91e0bc434389f/SearchServiceImages/2026-05-12-10-53-23-833-6a0306a3361a7892d984d7ee.jpg "Tile for The use of AI in the life sciences sector and the implications of GDPR")
/Passle/611cdc4cfac91e0bc434389f/MediaLibrary/Images/2026-01-09-15-03-35-734-696118c7cf4f3e55eb7b7ce6.jpg "Tile for Protecting, leveraging and enforcing IP around the world")
/Passle/611cdc4cfac91e0bc434389f/SearchServiceImages/2026-04-08-13-34-55-139-69d6597f654790a9a20b9d26.jpg "Tile for From space to science: how in‑orbit manufacturing is reshaping UK life sciences")
/Passle/611cdc4cfac91e0bc434389f/SearchServiceImages/2026-04-08-14-19-22-389-69d663ea0b6c99bfcd620173.jpg "Tile for Modernising UK clinical trials: what’s changing from April 2026")
/Passle/611cdc4cfac91e0bc434389f/MediaLibrary/Images/2026-01-28-17-18-07-429-697a44cf002f11719c9c313f.jpg "Tile for UK government position on text and data mining: what does it mean for the life sciences industry?")
/Passle/611cdc4cfac91e0bc434389f/SearchServiceImages/2026-03-19-17-38-39-693-69bc349fe368b2867c18a29c.jpg "Tile for Digital twins in clinical trials: emerging IP considerations")
/Passle/611cdc4cfac91e0bc434389f/MediaLibrary/Images/2026-01-28-17-13-31-399-697a43bbe8715be98459d195.jpg "Tile for Not quite Reddy – lessons on strategy for generic launches in the life sciences sector")
/Passle/611cdc4cfac91e0bc434389f/SearchServiceImages/2025-07-07-14-31-25-133-686bda3da2144a0551f28168.jpg "Tile for Healthcare financing and reimbursement in the UK – Stevens & Bolton’s recent contribution to the International Bar Association")